ir.adamispharmaceuticals.com ir.adamispharmaceuticals.com

ir.adamispharmaceuticals.com

Overview | Investors | Adamis

11682 El Camino Real, Suite # 300. San Diego, CA 92130. Investor Relations and Media Contact:. Director, Investor Relations and Corporate Communications. First American Stock Transfer. 4747 N. 7th Street, Suite # 170. Phoenix, AZ 85014. Mayer Hoffman McCann P.C. Http:/ www.mhm-pc.com. Weintraub Tobin Chediak Coleman Grodin. No Duty to Update. Data provided by Nasdaq. Minimum 15 minutes delayed. Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA.

http://ir.adamispharmaceuticals.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR IR.ADAMISPHARMACEUTICALS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Wednesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 15 reviews
5 star
9
4 star
0
3 star
4
2 star
0
1 star
2

Hey there! Start your review of ir.adamispharmaceuticals.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

7.8 seconds

FAVICON PREVIEW

  • ir.adamispharmaceuticals.com

    16x16

CONTACTS AT IR.ADAMISPHARMACEUTICALS.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Overview | Investors | Adamis | ir.adamispharmaceuticals.com Reviews
<META>
DESCRIPTION
11682 El Camino Real, Suite # 300. San Diego, CA 92130. Investor Relations and Media Contact:. Director, Investor Relations and Corporate Communications. First American Stock Transfer. 4747 N. 7th Street, Suite # 170. Phoenix, AZ 85014. Mayer Hoffman McCann P.C. Http:/ www.mhm-pc.com. Weintraub Tobin Chediak Coleman Grodin. No Duty to Update. Data provided by Nasdaq. Minimum 15 minutes delayed. Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA.
<META>
KEYWORDS
1 select page
2 overview
3 management
4 board of directors
5 lead pipeline product
6 epinephrine pfs
7 pipeline
8 specialty pharmaceuticals
9 partnerships
10 investors
CONTENT
Page content here
KEYWORDS ON
PAGE
select page,overview,management,board of directors,lead pipeline product,epinephrine pfs,pipeline,specialty pharmaceuticals,partnerships,investors,news releases,stock information,sec filings,email alerts,careers,print page,email page,corporate information
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Overview | Investors | Adamis | ir.adamispharmaceuticals.com Reviews

https://ir.adamispharmaceuticals.com

11682 El Camino Real, Suite # 300. San Diego, CA 92130. Investor Relations and Media Contact:. Director, Investor Relations and Corporate Communications. First American Stock Transfer. 4747 N. 7th Street, Suite # 170. Phoenix, AZ 85014. Mayer Hoffman McCann P.C. Http:/ www.mhm-pc.com. Weintraub Tobin Chediak Coleman Grodin. No Duty to Update. Data provided by Nasdaq. Minimum 15 minutes delayed. Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA.

OTHER SITES

ir.acsf.com ir.acsf.com

Investor Relations Home - Investor Relations - American Capital Senior Floating

Skip to main content. Dividend Reinvestment and Stock Purchase. Receive American Capital Senior Floating. 10-Q Q2 2015 (quarter ending June 30, 2015). 10-Q Q1 2015 (quarter ending March 31, 2015). American Capital Senior Floating, Ltd. Announces Monthly Cash Dividends of $0.097 per Share for August, September and October of 2015. American Capital Senior Floating Reports Net Investment Income of $0.32 per Share. American Capital Senior Floating, Ltd. Will Report Second Quarter 2015 Results on August 3.

ir.actiniumpharma.com ir.actiniumpharma.com

Investor Relations :: Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals to Present at 9th Annual Biotech Showcase™ 2017 Conference. Jan 10, 2017. Ended Sep 30, 2016. Actinium Pharmaceuticals, Inc. Actinium Pharmaceuticals, Inc. New York, NY 10016. 2469 E. Fort Union Blvd. Salt Lake City, UT 84121. Receive the latest news, events and updates! 2017 Actinium Pharmaceuticals, Inc.

ir.activepower.com ir.activepower.com

Investor Overview - Active Power Investors Relations

150 kVA â 1200 kVA). 750 kVA â 3 MVA). Our products are built on our elegant, field proven flywheel technology that delivers an unmatched combination of power density, reliability, and total cost of ownership. This combination enables our customers to achieve their availability, reliability, and budget goals. Q2 2015 Earnings Release. Q2 2015 Active Power, Inc. Earnings Conference Call. Q2 2015 â 10-Q. 160; 0.08. Data as of 08/07/15Â 4:00 pm ET. Minimum 20 minute delay. Active Power to Present at 43rd An...

ir.activisionblizzard.com ir.activisionblizzard.com

Activision Blizzard, Inc. | Investor Relations

Activision Blizzard, Inc. is the largest and most profitable western interactive entertainment publishing company. It develops and publishes some of the most successful and beloved entertainment franchises in any medium, including. Call of Duty,. Call of Duty Online,. Aug 6, 2015. Hellfire Rains on Azeroth in World of Warcraft: Legion™. Aug 5, 2015. Activision Brings Strongest Ever Line-up to Gamescom 2015. Aug 4, 2015 at 1:30 PM PT. Activision Blizzard Second Quarter Calendar 2015 Results Conference Call.

ir.adamaspharma.com ir.adamaspharma.com

Investors - Adamas Pharmaceuticals, Inc.

Scientific and Clinical Advisors. Please email ir@adamaspharma.com. For assistance with Investor Relations questions. Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system. The company seeks to achieve this by modifying the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products. 4:00 PM ET on Aug 14, 2015.

ir.adamispharmaceuticals.com ir.adamispharmaceuticals.com

Overview | Investors | Adamis

11682 El Camino Real, Suite # 300. San Diego, CA 92130. Investor Relations and Media Contact:. Director, Investor Relations and Corporate Communications. First American Stock Transfer. 4747 N. 7th Street, Suite # 170. Phoenix, AZ 85014. Mayer Hoffman McCann P.C. Http:/ www.mhm-pc.com. Weintraub Tobin Chediak Coleman Grodin. No Duty to Update. Data provided by Nasdaq. Minimum 15 minutes delayed. Adamis Pharmaceuticals Announces NDA Resubmission of Its Epinephrine Pre-Filled Syringe Application to the FDA.

ir.adcarehealth.com ir.adcarehealth.com

Home Page - AdCare Health Systems

15879 N. 80th Street. Scottsdale, AZ 85260. AdCare Health Systems seeks to enhance shareholder value not only through exceptional. Business performance and practices, but also through responsible and effective. Communication with its shareholders. The latest company information relevant to the. Individual and institutional investor includes stock price and history, upcoming events and. Presentations and financial documents. AdCare Health Systems is traded on the NYSE under the ticker symbol ADK. See impo...

ir.adecoagro.com ir.adecoagro.com

Adecoagro

Presentation and Conference Calls. 20-F 2016 Annual Report. Mariano Bosch (CEO) live on Bloomberg TV. Listen to Webcast (Portuguese). Listen to Webcast (English). Adecoagro Presentó a SanCor una Alternativa de Inversión y Asociación. Click para más información. Adecoagro Submits Investment Proposal to Partner with SanCor. Click here for more information.

ir.adept.com ir.adept.com

Adept Technology, Inc. - Investor Relations

Adept Technology, Inc. Aug 7, 2015. Quotes delayed at least 20 minutes. Information provided by eSignal. The Company has been featured in several publications including Fortune, Inc., Business Week, Forbes ASAP, Red Herring, Industry Week. And The New York Times. Adept Technology will be the global leader in the manufacturing, marketing and innovation of robotics, vision and motion control products for automated material handling and assembly. Click here for 2014 Proxy information. Jul 27, 2015.

ir.adeptushealth.com ir.adeptushealth.com

Adeptus Health Inc. - IR Home

A new holding company focused on premier healthcare organizations that provide communities access to the highest quality medical care. August 14, 2015. July 29, 2015. Adeptus Health Inc. Announces Pricing of Common Stock Offering. July 27, 2015. Adeptus Health Inc. Announces Common Stock Offering. July 23, 2015. Adeptus Health Reports Second Quarter 2015 Results And Raises Full Year Guidance. There are no events scheduled at this time. Powered By Q4 Web Systems.

ir.adestotech.com ir.adestotech.com

Investor Home | Investor Relations | Adesto

The Internet of Things. Quality and Support Documentation. Inventing Memory for Things. Adesto provides smart, application-specific memory solutions for the IoT. The Internet of Things. Introducing Fusion Serial Flash. For wearable, wireless and other energy-conscious applications. Announcements and articles featuring Adesto products and technologies. Find the right product or other support for your application. Quality and Support Documentation. 160;at 10:00 am ET. Thursday, January 12, 2017 . Mavriq DS...